Raw Material Medicine Manufacturing
|
US$
75 |
Apr-2021 |
Doc #34338 |
|
Printed Page Length :
12
pages |
Number of Tables :
3 |
Number of Figures:
2 |
Market Overview
|
Global demand for antibiotic-specific active pharmaceutical ingredients for the treatment of severely ill COVID-19 patients remains strong. Moreover, the gradual restructuring of the pharmaceutical supply chains in Europe and America augurs well for Taiwan firms dedicated to niche products, helping expand the export markets in the first half of 2021.
|
|
|